# Phenylethanoid Glycosides from Cistanche deserticola Y. C. Ma: Synergistic Effects, Multi-target Mechanisms and Translational Applications

**Authors:** Xiaofeng Liu, Minjun Han, Zichao Yang, Zherui Chen, Yao Zhang, Rongfa Guan

PMC · DOI: 10.3390/nu18050725 · Nutrients · 2026-02-24

## TL;DR

This paper reviews the bioactive compounds in Cistanche deserticola, highlighting their multi-target effects and potential for treating chronic diseases.

## Contribution

The paper systematically summarizes the structure–activity relationships and pharmacological mechanisms of phenylethanoid glycosides from Cistanche deserticola.

## Key findings

- PhGs regulate multiple signaling pathways like NF-κB and Nrf2/HO-1 to exert anti-inflammatory and antioxidant effects.
- These compounds show potential in treating Alzheimer’s disease, osteoporosis, and oxidative stress-induced injuries.
- Future research should focus on improving bioavailability and understanding synergistic mechanisms.

## Abstract

Background: Cistanche deserticola Y. C. Ma (C. deserticola) is a widely recognized medicinal and edible homologous plant. Phenylethanoid glycosides (PhGs), as its dominant bioactive components, are characterized by diverse chemical structures and prominent multi-target synergistic pharmacological activities. This review aims to systematically outline the structural characteristics, structure–activity relationships, and pharmacological mechanisms of typical PhGs from C. deserticola, so as to provide a scientific basis for their further development and application. Methods: A comprehensive literature review was performed. The structural features, structure–activity relationships, and multi-dimensional pharmacological mechanisms of representative PhGs, including echinacoside, verbascoside, and cistanoside A, were systematically summarized and analyzed. Results: PhGs exert anti-inflammatory, antioxidant, immunomodulatory, neuroprotective, antitumor, and hepatoprotective effects mainly by regulating multiple signaling pathways, such as NF-κB, MAPK, PI3K/Akt, and Nrf2/HO-1. These compounds display promising application potential in the prevention and amelioration of chronic inflammatory diseases, aging-related disorders including Alzheimer’s disease and osteoporosis, as well as oxidative stress-induced injury. Conclusions: PhGs from C. deserticola possess distinct pharmacological effects and broad application prospects. Future research should emphasize in-depth structure–activity relationship investigations, multi-component synergistic mechanisms, safety evaluation, and formulation design to enhance bioavailability, thus promoting the industrial development and application of PhGs.

## Linked entities

- **Proteins:** NFKB1 (nuclear factor kappa B subunit 1), MAPK (mitogen activated kinase-like protein)
- **Chemicals:** echinacoside (PubChem CID 5281771), verbascoside (PubChem CID 5281800), cistanoside A (PubChem CID 71307448)
- **Diseases:** Alzheimer’s disease (MONDO:0004975), osteoporosis (MONDO:0005298)
- **Species:** Cistanche deserticola (taxon 161395)

## Full-text entities

- **Diseases:** Alzheimer's disease (MESH:D000544), osteoporosis (MESH:D010024), inflammatory (MESH:D007249)
- **Chemicals:** echinacoside (MESH:C060297), cistanoside A (MESH:C555977), PhGs (-), verbascoside (MESH:C058956)
- **Species:** Cistanche deserticola (species) [taxon 161395]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12987270/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12987270/full.md

## References

108 references — full list in the complete paper: https://tomesphere.com/paper/PMC12987270/full.md

---
Source: https://tomesphere.com/paper/PMC12987270